Microsoft word - gemini shipper group output - april 2004.doc
Gemini Project – Shipper Group Workshop 27 April 2004 Radisson Grafton Hotel, London Present: Jill Griffin – NGT Fran Miles – NGT Stephen MacPherson – Attachmate David Lazarus – Attachmate Dave Roberts – BGT Mike Carter – BGT Nick Gold - BGT Mark Mugglestone – Exxonmobil Stuart Wing – Shell Energy Michael Reid – Scottish Power Kevan Tate – SSE Noel Regan – Bord Gais Richard Norris – Sungard Tony Byrne – Corona Tim Johnson – Powergen Nonie Toogood – Powergen Jamie Walsh – Powergen Jaivanti Maisuria – Conoco Phillips Sarah Stevens – Statoil Warren Collins – Statoil Bob Davis – RWE Innogy Derek Lewies – RWE Innogy Yasmin Sufi – ENI UK Gavin Pickering – Total Gas & Power Neil Dewar – APX Group David Hutchinson – Hess Energy Keith Stanton – Sempra Harb Sidhu – Centrica Storage Iain Chalmers – Allegro Development Nick Barney – NGT Simon Cave – NGT Susan Knights – NGT John Regan – NGT Steve Thompson – NGT Dave Williamson - NGT Note – Not all attendees signed the register.
C:\Documents and Settings\transco\Local Settings\Temporary Internet Files\OLK12\Gemini Shipper Group Output - April 2004.doc 5 May 2004
Workshop Content The Workshop opened with an introduction by Susan Knights who explained that the aim of the forum was to provide an update on the Entry Capacity and Energy Balancing/Exit Capacity release timescales and to facilitate a discussion on the interfacing options for the Energy Balancing release. Susan provided an update to the Issues Log. The following Issues were updated: GPSG29 – Open. GPSG66 – Closed. GPSG67 – Closed. GPSG68 – Closed. GPSG69 – Still being investigated. GPSG70 – Closed. Two new issues will be logged: The community asked NGT to establish whether it is viable to provide a separate test environment for EB for a longer period. NGT agreed to establish whether XP1 is going to be offered as contingency for the EB release. Entry Capacity Project Update John Regan, Programme Manager, shared a presentation that gave updated timelines for the Entry Capacity release. The key milestones were shared and these included confirmation of the following: Activity Date Connectivity Testing
Simon Cave, O&T Project Coordination Manager, then talked through the programme for the Shipper Trials for the Entry Capacity release. Simon explained that the Trials provided an opportunity for the community to gain further familiarity with the system and to examine their migrated data. It also provides an opportunity for organisations to place bids against specified auctions and to register/confirm trades. During the Trials organisations will also be available to familiarise themselves with the new ECBB On Line Tender Process. It allows a trial of the API functionality that is being provided under the Entry Capacity release.
C:\Documents and Settings\transco\Local Settings\Temporary Internet Files\OLK12\Gemini Shipper Group Output - April 2004.doc 5 May 2004
Simon talked through the three-week timetable and also explained the support process for the Trials. Dave Williamson, Gemini Technical Manager, provided a summary of the End-to-End Testing that had been carried out with a number of organisations within the community. Dave confirmed that the results had been as expected and that performance had greatly improved. The testing included screens and APIs with a variety of combinations of O/S and third party application versions. NGT confirmed this had been a very useful information gathering exercise and thanked those organisations that had supported the activity. It was brought to NGT’s attention that the UK Link Committee still feel they need to ratify the Gemini implementation plan. Susan explained that this was not the case as the formal governance process had been followed by the project and Susan agreed to take this up directly with the Committee. Energy Balancing/Exit Capacity Project Update John Regan provided an update on the timescales for the Energy Balancing/Exit Capacity release and confirmed that there will be a phased cutover commencing 31/03/05 with a Go Live date of 07/04/05. Further detailed information on this release will be shared in future Workshops. Feedback from the community identified that more time may be required for Shipper Trials. The community also asked whether it was feasible for them to have a separate test environment for a longer period. There were some concerns about the release date as it conflicts with the BETTA Go Live date. John then opened a discussion on the interfacing issues for the Energy Balancing/Exit Capacity release following the email from NGT in March acknowledging that the introduction of the revised infrastructure with the Citrix client would make screen scraping technically challenging. There was a great deal of discussion about alternative options including more APIs and a secondary Internet based access that would allow scraping to continue. With regard to the extra APIs, NGT agreed to write out and reconfirm API requirements with the community so that the project could understand the requirement. John Regan agreed to share the feedback from the community with the Programme Board at their next meeting in early May. A further meeting will be held with the community in early June to progress this. All of the presentations shared at the Forum can be found on the Shipper Web Site (Gemini page).
C:\Documents and Settings\transco\Local Settings\Temporary Internet Files\OLK12\Gemini Shipper Group Output - April 2004.doc 5 May 2004
C:\Documents and Settings\transco\Local Settings\Temporary Internet Files\OLK12\Gemini Shipper Group Output - April 2004.doc 5 May 2004
HiMedia Laboratories Cetrimide Agar Base Cetrimide Agar Base is used for the selective e isolation of Pseudomonas aeruginosa from clinical specimens. Composition** Ingredients **Formula adjusted, standardized to suit performance parameters Directions Suspend 46.7 grams in 1000 ml distilled water containing 10 ml glycerol. Heat, to boiling, to dissolve the medium completely. Steriliz
Farmakologian tenttitärpit Ensimmäinen välitentti Lyhyet kysymykset Sisällys Sivu 5 Biologinen hyötyosuus Sivu 6 Glukokortikoidit C Vaattovaara & DC Halonen 1. Määrittele lyhyesti käsite desensiti- 3. Määrittele käsite lyhyesti fysiologinen saatio ja sen taustalla olevat molekylaa- antagonismi ja sen taustalla olevat mole- riset mekanismit. Anna esimerkki.